Cargando…

Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022

OBJECTIVES: This study aims to investigate molecular epidemiology and clinical characteristics of enterovirus associated hand-foot-mouth disease (HFMD) in Chengdu, China, 2013–2022. Monitoring the molecular epidemiology and clinical features of HFMD for up to 10 years may provide some ideas for futu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiuxia, Liu, Fang, Chang, Li, Lai, Shuyu, Teng, Jie, Duan, Jiaxin, Jian, Hui, Liu, Ting, Che, Guanglu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476316/
https://www.ncbi.nlm.nih.gov/pubmed/37661256
http://dx.doi.org/10.1186/s12985-023-02169-x
_version_ 1785100902278889472
author Yang, Qiuxia
Liu, Fang
Chang, Li
Lai, Shuyu
Teng, Jie
Duan, Jiaxin
Jian, Hui
Liu, Ting
Che, Guanglu
author_facet Yang, Qiuxia
Liu, Fang
Chang, Li
Lai, Shuyu
Teng, Jie
Duan, Jiaxin
Jian, Hui
Liu, Ting
Che, Guanglu
author_sort Yang, Qiuxia
collection PubMed
description OBJECTIVES: This study aims to investigate molecular epidemiology and clinical characteristics of enterovirus associated hand-foot-mouth disease (HFMD) in Chengdu, China, 2013–2022. Monitoring the molecular epidemiology and clinical features of HFMD for up to 10 years may provide some ideas for future protection and control measures. METHODS: We conducted a retrospective analysis of the medical records of all patients with laboratory-confirmed HFMD-related enterovirus infection at the West China Second University Hospital from January 2013 to December 2022. We described the characteristics in serotype, age, sex distribution and hospitalization of enterovirus infection cases using data analysis and graphic description. RESULTS: A total of 29,861 laboratory-confirmed cases of HFMD-related enterovirus infection were reported from 2013 to 2022. There was a significant reduction in the number and proportion of EV-A71 cases after 2016, from 1713 cases (13.60%) in 2013–2015 to 150 cases (1.83%) in 2017–2019. During the COVID-19 pandemic, EV-A71 cases even disappeared. The proportion of CV-A16 cases decreased from 13.96% in 2013–2015 to 10.84% in 2017–2019 and then to 4.54% in 2020–2022. Other (non-EV-A71 and non-CV-A16) serotypes accounted for 95.45% during 2020–2022, with CV-A6 accounting for 50.39% and CV-A10 accounting for 10.81%. Thus, CV-A6 and CV-A10 became the main prevalent serotypes. Furthermore, There was no significant difference in the enterovirus prevalence rate between males and females. The hospitalization rate of EV-A71 patients was higher that of other serotypes. In general, the proportion of HFMD hospitalizations caused by other pathogens except for EV-A71, CV-A16, CV-A10 and CV-A16 was second only to that caused by EV-A71. The proportion of children over 4 years old infected with enterovirus increased. CONCLUSION: The incidence of HFMD associated with enterovirus infection has decreased significantly and CV-A6 has been the main pathogen of HFMD in Chengdu area in recent years. The potential for additional hospitalizations for other untested enterovirus serotypes suggested that attention should also be paid to the harms of infections with unknown enterovirus serotypes. Children with HFMD were older. The development of new diagnostic reagents and vaccines may play an important role in the prevention and control of enterovirus infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02169-x.
format Online
Article
Text
id pubmed-10476316
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104763162023-09-05 Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022 Yang, Qiuxia Liu, Fang Chang, Li Lai, Shuyu Teng, Jie Duan, Jiaxin Jian, Hui Liu, Ting Che, Guanglu Virol J Research OBJECTIVES: This study aims to investigate molecular epidemiology and clinical characteristics of enterovirus associated hand-foot-mouth disease (HFMD) in Chengdu, China, 2013–2022. Monitoring the molecular epidemiology and clinical features of HFMD for up to 10 years may provide some ideas for future protection and control measures. METHODS: We conducted a retrospective analysis of the medical records of all patients with laboratory-confirmed HFMD-related enterovirus infection at the West China Second University Hospital from January 2013 to December 2022. We described the characteristics in serotype, age, sex distribution and hospitalization of enterovirus infection cases using data analysis and graphic description. RESULTS: A total of 29,861 laboratory-confirmed cases of HFMD-related enterovirus infection were reported from 2013 to 2022. There was a significant reduction in the number and proportion of EV-A71 cases after 2016, from 1713 cases (13.60%) in 2013–2015 to 150 cases (1.83%) in 2017–2019. During the COVID-19 pandemic, EV-A71 cases even disappeared. The proportion of CV-A16 cases decreased from 13.96% in 2013–2015 to 10.84% in 2017–2019 and then to 4.54% in 2020–2022. Other (non-EV-A71 and non-CV-A16) serotypes accounted for 95.45% during 2020–2022, with CV-A6 accounting for 50.39% and CV-A10 accounting for 10.81%. Thus, CV-A6 and CV-A10 became the main prevalent serotypes. Furthermore, There was no significant difference in the enterovirus prevalence rate between males and females. The hospitalization rate of EV-A71 patients was higher that of other serotypes. In general, the proportion of HFMD hospitalizations caused by other pathogens except for EV-A71, CV-A16, CV-A10 and CV-A16 was second only to that caused by EV-A71. The proportion of children over 4 years old infected with enterovirus increased. CONCLUSION: The incidence of HFMD associated with enterovirus infection has decreased significantly and CV-A6 has been the main pathogen of HFMD in Chengdu area in recent years. The potential for additional hospitalizations for other untested enterovirus serotypes suggested that attention should also be paid to the harms of infections with unknown enterovirus serotypes. Children with HFMD were older. The development of new diagnostic reagents and vaccines may play an important role in the prevention and control of enterovirus infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02169-x. BioMed Central 2023-09-03 /pmc/articles/PMC10476316/ /pubmed/37661256 http://dx.doi.org/10.1186/s12985-023-02169-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Qiuxia
Liu, Fang
Chang, Li
Lai, Shuyu
Teng, Jie
Duan, Jiaxin
Jian, Hui
Liu, Ting
Che, Guanglu
Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title_full Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title_fullStr Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title_full_unstemmed Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title_short Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022
title_sort molecular epidemiology and clinical characteristics of enteroviruses associated hfmd in chengdu, china, 2013–2022
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476316/
https://www.ncbi.nlm.nih.gov/pubmed/37661256
http://dx.doi.org/10.1186/s12985-023-02169-x
work_keys_str_mv AT yangqiuxia molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT liufang molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT changli molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT laishuyu molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT tengjie molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT duanjiaxin molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT jianhui molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT liuting molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022
AT cheguanglu molecularepidemiologyandclinicalcharacteristicsofenterovirusesassociatedhfmdinchengduchina20132022